// App-Quantinova.ai

BS31 : The senescence-associated secretory phenotype as a biomarker for age-related myocardial remodelling and cardiovascular disease

Researchers

Presenter

  • Laura Booth

Principal Investigators

  • Rachael Redgrave

  • Maria Camacho Encina

  • Simon Tual-Chalot

  • Omowumi Folaranmi

  • Carmen Martin-Ruiz

  • Ioakim Spyridopoulos

  • Jason Gill

  • Gavin Richardson

Medical Centers

  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK, Institute of Genetic Medicine Centre for Life, Central Pkway Newcastle Upon Tyne, TWR NE BZ United Kingdom, UK

  • Bio Screening Core Facility, Newcastle University, UK

  • Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK

  • Biosciences Institute, Newcastle University, UK

  • Bioscience Institute, Vascular Biology and Medicine Theme, Newcastle University, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

Biomarkers

  • Fractalkine

  • Growth differentiation factor 15

  • Thioredoxin

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Doxorubicin

  • Sulfasalazine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved